Jefferies Says Dynavax (DVAX) Should Be Bought on Weakness

March 4, 2013 10:25 AM

Jefferies reiterated its Buy rating and $5 price target on Dynavax Technologies (NASDAQ: DVAX) following Q4 results saying the stock ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found